- CA$23.38m
- CA$26.27m
- CA$0.49m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.326 | 0.332 | 0.267 | 0.439 | 0.486 |
Cost of Revenue | |||||
Gross Profit | -0.759 | -0.473 | -0.348 | -0.418 | -0.307 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.26 | 3.46 | 2.55 | 3.1 | 2.72 |
Operating Profit | -2.93 | -3.13 | -2.28 | -2.66 | -2.24 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.9 | -3.38 | -2.05 | -2.61 | -2.48 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.84 | -3.38 | -2.05 | -2.61 | -2.48 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.84 | -3.38 | -2.05 | -2.61 | -2.48 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.84 | -3.38 | -2.05 | -2.61 | -2.48 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.204 | -0.075 | -0.033 | -0.038 | -0.036 |